Sanofi Improperly Listed Lantus Patent In FDA's Orange Book, Appeals Court Finds

Justice in front of Law
Appeals court revives antitrust claims against Sanofi for improper patent listing in FDA's Orange Book
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legal & IP

More from Pink Sheet